Sharp Therapeutics
Sharp Therapeutics
Categories
Biotech Pharmaceutical
About
Sharp Edge is bringing a new class of targeted biosensors to the cellular biology research community. Fluorogenic Activating Protein (or FAPs) provide a more accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and more detailed follow-up. He has wicked dyes, and is a CMU spin out. 5/19/15 update: they have created a molecular tracking device to detect defective routing by cells. Can be used for Alzheimers, Parkinsons, Cancer/Oncology. They have many partners and provide pre-clinical testing services. Also working with Patient Foundations. *The most revenue ever generated by a CMU spin-out.
Get Updates
from LSPA
Stay up-to-date on the latest news and events from Life Sciences PA, insights from the life sciences industry, and so much more!
Life Sciences Pennsylvania was founded in 1989 by a biotech scientist at Penn State University. Today it has grown to represent the entire life sciences industry – biotechnology and diagnostic companies, medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.